Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Citalopram on LES function in healthy subjects
NCT03746691Phase 4Completed
- Sponsor
- UZ Leuven
- Start
- Feb 2017
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in gastroesophageal reflux disease (GERD) comparing Citalopram Sequence with Placebo Sequence (2 arms). Primary endpoints: Lower Esophageal Sphincter pressure, Number of reflux episodes at 3 hours and 1 more. Started Feb 2017; status: completed.
02
Drugs
citalopram
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT03746691.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03746691.